TY - JOUR
T1 - Targeted Cyclo[8]pyrrole-Based NIR-II Photoacoustic Tomography Probe for Suppression of Orthotopic Pancreatic Tumor Growth and Intra-abdominal Metastases
AU - Chen, Jingqin
AU - Chen, Rui
AU - Chau, Calvin V.
AU - Sedgwick, Adam C.
AU - Xue, Qiang
AU - Chen, Tao
AU - Zeng, Silue
AU - Chen, Ningbo
AU - Wong, Kenneth k. y.
AU - Song, Liang
AU - Ren, Yaguang
AU - Yang, Jian
AU - Sessler, Jonathan l.
AU - Liu, Chengbo
N1 - Funding Information:
The work was supported by grants from the National Key R&D Program of China (2022YFE0132300, 2023YFF0715300, 2023YFC2411700 to C.L., 2020YFA0908800 to J.C.); the National Natural Science Foundation of China (82172008 to J.C., 82122034, 82327805, 81927807 to C.L., 82272132 to J.Y.); the Youth Innovation Promotion Association, Chinese Academy of Sciences (2023374 to J.C. and 2019352 to C.L.); the Shenzhen Science and Technology Innovation Grant (JCYJ20220818101403008 to C.L.); the Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences; Guangdong Provincial Key Laboratory of Biomedical Optical Imaging (2020B121201010 to J.C.); Shenzhen Key Laboratory for Molecular Imaging (ZDSY20130401165820357 to L.S.); Basic and Applied Basic Research Foundation of Guangdong Province (2019A1515110727 to Y.R.). The work in Austin was supported by the Robert A. Welch Foundation (F-0018 to J.S.) and by NIH grant RO1 CA68682 subsequent to June 2022.
Publisher Copyright:
© 2024 American Chemical Society.
PY - 2024/2/8
Y1 - 2024/2/8
N2 - Pancreatic cancer is highly lethal. New diagnostic and treatment modalities are desperately needed. We report here that an expanded porphyrin, cyclo[8]pyrrole (CP), with a high extinction coefficient (89.16 L/g·cm) within the second near-infrared window (NIR-II), may be formulated with an αvβ3-specific targeting peptide, cyclic-Arg-Gly-Asp (cRGD), to form cRGD-CP nanoparticles (cRGD-CPNPs) with promising NIR-II photothermal (PT) therapeutic and photoacoustic (PA) imaging properties. Studies with a ring-array PA tomography system, coupled with analysis of control nanoparticles lacking a targeting element (CPNPs), revealed that cRGD conjugation promoted the delivery of the NPs through abnormal vessels around the tumor to the solid tumor core. This proved true in both subcutaneous and orthotopic pancreatic tumor mice models, as confirmed by immunofluorescent studies. In combination with NIR-II laser photoirradiation, the cRGD-CPNPs provided near-baseline tumor growth inhibition through PTT both in vitro and in vivo. Notably, the combination of the present cRGD-CPNPs and photoirradiation was found to inhibit intra-abdominal metastases in an orthotopic pancreatic tumor mouse model. The cRGD-CPNPs also displayed good biosafety profiles, as inferred from PA tomography, blood analyses, and H&E staining. They thus appear promising for use in combined PA imaging and PT therapeutic treatment of pancreatic cancer.
AB - Pancreatic cancer is highly lethal. New diagnostic and treatment modalities are desperately needed. We report here that an expanded porphyrin, cyclo[8]pyrrole (CP), with a high extinction coefficient (89.16 L/g·cm) within the second near-infrared window (NIR-II), may be formulated with an αvβ3-specific targeting peptide, cyclic-Arg-Gly-Asp (cRGD), to form cRGD-CP nanoparticles (cRGD-CPNPs) with promising NIR-II photothermal (PT) therapeutic and photoacoustic (PA) imaging properties. Studies with a ring-array PA tomography system, coupled with analysis of control nanoparticles lacking a targeting element (CPNPs), revealed that cRGD conjugation promoted the delivery of the NPs through abnormal vessels around the tumor to the solid tumor core. This proved true in both subcutaneous and orthotopic pancreatic tumor mice models, as confirmed by immunofluorescent studies. In combination with NIR-II laser photoirradiation, the cRGD-CPNPs provided near-baseline tumor growth inhibition through PTT both in vitro and in vivo. Notably, the combination of the present cRGD-CPNPs and photoirradiation was found to inhibit intra-abdominal metastases in an orthotopic pancreatic tumor mouse model. The cRGD-CPNPs also displayed good biosafety profiles, as inferred from PA tomography, blood analyses, and H&E staining. They thus appear promising for use in combined PA imaging and PT therapeutic treatment of pancreatic cancer.
UR - http://www.scopus.com/inward/record.url?scp=85185621803&partnerID=8YFLogxK
U2 - 10.1021/jacs.3c11666
DO - 10.1021/jacs.3c11666
M3 - Article
SN - 0002-7863
VL - 146
SP - 4620
EP - 4631
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 7
ER -